Literature DB >> 627614

Complex nature of serum lysozyme activity: evidence of thermolability in inflammatory bowel disease.

M Ward, W D Mitchell, M Eastwood.   

Abstract

In patients with Crohn's disease and ulcerative colitis, alterations in serum storage temperature produced significant changes in serum lysozyme activity (SLA) as measured by the lysoplate method. This was not the case in healthy controls or in a group with other gastrointestinal disorders. Electrophoretic separation of serum revealed two components of lysozyme-type lytic activity but only one in extracts of gut mucosa, leucocytes, and egg white. The major lytic component of serum migrated towards the cathode and reacted with specific antilysozyme serum, but the minor component which migrated towards the anode did not. Although the cause of this anionic lytic activity is uncertain, it contributes to total serum activity as estimated by any method utilising the lysis of Micrococcus lysodeikticus, and may possibly be related to the observed thermolability.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627614      PMCID: PMC476716          DOI: 10.1136/jcp.31.1.39

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Factors influencing lysozyme determinations by the lysoplate method.

Authors:  T L Peeters; G R Vantrappen
Journal:  Clin Chim Acta       Date:  1977-02-01       Impact factor: 3.786

2.  Definitions of inflammatory bowel disease of unknown etiology.

Authors:  H Schachter; J B Kirsner
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

3.  Serum lysozyme in inflammatory bowel disease.

Authors:  F W Nugent; R Mallari; H George; N Ridley
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

4.  Serum lysozyme in inflammatory bowel disease.

Authors:  M W Dronfield; M J Langman
Journal:  Gut       Date:  1975-12       Impact factor: 23.059

5.  Serum lysozyme in inflammatory bowel and coeliac disease.

Authors:  E Mallas; J M Terry; P Asquith; W T Cooke
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

6.  Electrophoresis of lysozyme into Microscoccus-containing agarose gel: quantitative and analytical applications.

Authors:  G Virella
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786

7.  Monoclonal IgG-lysozyme (muramidase) complex in acute myelomonocytic leukemia: an unusual finding.

Authors:  H I Finkle; K Brownlow; F R Elevitch
Journal:  Am J Clin Pathol       Date:  1973-12       Impact factor: 2.493

8.  Interaction between lysozyme and some lactoferrin complex in human milk.

Authors:  J P Perraudin; J P Prieels; J Léonis
Journal:  Arch Int Physiol Biochim       Date:  1974-12

9.  The electrophoretic mobility of serum lysozyme.

Authors:  G Virella
Journal:  Experientia       Date:  1975-12-15

Review 10.  Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Authors:  T L Peeters; G Vantrappen; K Geboes
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

View more
  3 in total

1.  Serum lysozyme levels in malignant histiocytosis of the intestine.

Authors:  J R Hodges; P Isaacson; O E Eade; R Wright
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

2.  Serum lysozyme: is it a useful marker of malignant lymphoma in coeliac disease?

Authors:  M A Bourke; D M McLoughlin; F M Stevens; C F McCarthy
Journal:  Ir J Med Sci       Date:  1983-03       Impact factor: 1.568

3.  Serum lysozyme activity in coeliac disease: a possible aid to athe diagnosis of malignant change.

Authors:  B T Cooper; S O Ukabam; R E Barry; A E Read
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.